LPCN
LPCN
NASDAQ · Pharmaceuticals

Lipocine Inc

$2.17
+0.00 (+0.00%)
As of Aug 8, 2:20 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +794.5% upside
Low Target $13.09
Average Target $19.41
High Target $19.72
Current Price $2.17
Current
$2.17
Target
$19.41
$13.09 $19.41 avg $19.72
Scenario Analysis
Bear Case
$13.09
503.2%
Low target
Base Case
$19.41
+794.5%
Avg target
Bull Case
$19.72
+808.8%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$12.37
-82.5% from high
52-Week Low
$1.81
+19.9% from low
Target vs 52W High
$19.41
+56.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%